Boehringer Ingelheim works on breakthrough therapies that transform lives of current and future generations. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Since the foundation in 1885, Boehringer Ingelheim has been family-owned with a long-term perspective. More than 52,000 employees serve over 130 markets in three business areas: Human Pharmaceuticals, Animal Health and Biopharmaceutical Contract Manufacturing.